Center for Zoo and Wild Animal Health, Copenhagen Zoo, Frederiksberg, Denmark.
Department of Ethology and Wildlife, Veterinary College, National Autonomous University of Mexico, Mexico City, Mexico.
Vet Anaesth Analg. 2021 May;48(3):372-379. doi: 10.1016/j.vaa.2020.08.012. Epub 2021 Feb 22.
To compare cardiovascular and ventilatory effects, immobilization quality and effects on tissue perfusion of a medetomidine-ketamine-midazolam combination with or without vatinoxan (MK-467), a peripherally acting α-adrenoceptor antagonist.
Randomized, blinded, crossover study.
A group of nine healthy Patagonian maras (Dolichotis patagonum).
Maras were immobilized twice with: 1) medetomidine hydrochloride (0.1 mg kg) + ketamine (5 mg kg) + midazolam (0.1 mg kg) (MKM) + saline or 2) MKM + vatinoxan hydrochloride (0.8 mg kg), administered intramuscularly. Drugs were mixed in the same syringe. At 20, 30 and 40 minutes after injection, invasive blood pressure, heart rate, respiration rate, end-tidal CO, haemoglobin oxygen saturation, and muscle oxygenation were measured, arteriovenous oxygen content difference was calculated. Muscle tone, jaw tone, spontaneous blinking and palpebral reflex were evaluated. Times to initial effect, recumbency, initial arousal and control of the head were recorded. Paired t test, Wilcoxon matched-pairs signed rank test and analysis of variance were used to compare protocols; (p < 0.05).
Vatinoxan significantly reduced systolic (p = 0.0002), mean (MAP; p < 0.0001) and diastolic (p < 0.0001) arterial blood pressures between 20 and 40 minutes. MAPs at 30 minutes (mean ± standard deviation) with MKM and MKM + vatinoxan were 105 ± 12 and 71 ± 14 mmHg, respectively. Without vatinoxan, four animals were hypertensive (MAP > 120 mmHg), whereas with vatinoxan, four animals were hypotensive (MAP < 60 mmHg). Muscle and jaw tone were significantly more frequently present with MKM (both p = 0.039). Other measurements did not significantly differ between protocols.
In Patagonian maras, vatinoxan attenuated the increase in blood pressure induced by medetomidine. Muscle and jaw tone were more frequently present with MKM, indicating that quality of immobilization with vatinoxan was more profound.
比较甲磺酸右美托咪定-氯胺酮-咪达唑仑(MK-467)联合或不联合外周作用的 α 肾上腺素受体拮抗剂戊噻肟(vatinoxan)对心血管和通气效果、固定质量以及组织灌注的影响。
随机、双盲、交叉研究。
一组 9 只健康的巴塔哥尼亚马(Dolichotis patagonum)。
马被两次固定:1)盐酸右美托咪定(0.1mg/kg)+氯胺酮(5mg/kg)+咪达唑仑(0.1mg/kg)(MKM)+生理盐水或 2)MKM+盐酸戊噻肟(0.8mg/kg),肌肉内给药。药物在同一注射器中混合。在注射后 20、30 和 40 分钟时,测量有创血压、心率、呼吸频率、呼气末 CO、血红蛋白氧饱和度和肌肉氧合,并计算动静脉氧含量差。评估肌肉张力、下颌张力、自发眨眼和眼睑反射。记录初始效果、卧倒、初始觉醒和头部控制的时间。使用配对 t 检验、Wilcoxon 配对符号秩检验和方差分析比较方案;(p<0.05)。
戊噻肟显著降低了 20 至 40 分钟时的收缩压(p=0.0002)、平均动脉压(MAP;p<0.0001)和舒张压(p<0.0001)。MKM 和 MKM+戊噻肟在 30 分钟时的 MAP 平均值(标准偏差)分别为 105±12mmHg 和 71±14mmHg。没有戊噻肟时,4 只动物血压升高(MAP>120mmHg),而有戊噻肟时,4 只动物血压降低(MAP<60mmHg)。MKM 时肌肉和下颌张力更频繁出现(均 p=0.039)。其他测量值在方案之间无显著差异。
在巴塔哥尼亚马中,戊噻肟减轻了由右美托咪定引起的血压升高。MKM 时肌肉和下颌张力更频繁出现,表明戊噻肟固定质量更深。